Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
9,203.00
7,895.00
6,658.00
5,985.00
5,855.00
5,033.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
9,203.00
7,895.00
6,658.00
5,985.00
5,855.00
5,033.00
Expenditure (Ex Depriciation)
Stock Adjustments
-432.00
-263.00
-190.00
66.00
-145.00
-303.00
Raw Materials Consumed
4,090.00
3,410.00
2,665.00
2,193.00
2,378.00
2,188.00
Power & Fuel Cost
135.00
137.00
120.00
108.00
97.00
94.00
Employee Cost
1,552.00
1,446.00
1,292.00
1,117.00
1,011.00
904.00
Operating Expenses
443.00
351.00
287.00
261.00
271.00
290.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
746.00
592.00
534.00
414.00
397.00
121.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
306.00
190.00
195.00
157.00
142.00
240.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
7,457.00
6,427.00
5,428.00
4,804.00
4,525.00
3,817.00
Operating Profit (PBDIT) excl Other Income
1,745.00
1,468.00
1,229.00
1,181.00
1,329.00
1,216.00
Other Income
131.00
72.00
56.00
45.00
63.00
33.00
Operating Profit (PBDIT)
1,877.00
1,541.00
1,286.00
1,227.00
1,393.00
1,250.00
Interest
143.00
175.00
237.00
213.00
175.00
154.00
Profit before Depriciation and Tax
1,733.00
1,365.00
1,049.00
1,013.00
1,217.00
1,095.00
Depreciation
415.00
384.00
312.00
260.00
244.00
249.00
Profit Before Taxation & Exceptional Items
1,318.00
981.00
737.00
753.00
972.00
845.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,287.00
971.00
727.00
747.00
972.00
840.00
Provision for Tax
345.00
263.00
199.00
185.00
269.00
233.00
Profit After Tax
941.00
707.00
527.00
561.00
702.00
607.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,312.00
2,634.00
2,196.00
1,695.00
1,743.00
1,368.00
Profit Available for appropriations
4,237.00
3,315.00
2,694.00
2,227.00
2,406.00
1,976.00
Appropriations
4,237.00
3,315.00
2,694.00
2,227.00
2,406.00
1,976.00
Equity Dividend (%)
36.00%
30.00%
20.00%
20.00%
30.00%
10.00%
Earnings Per Share
48.77
36.43
27.54
29.42
36.62
21.68
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 16.56% vs 18.59% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 18.85% vs 19.45% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -18.27% vs -25.88% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 33.05% vs 34.10% in Mar 2025
Compare Profit and Loss Results of Emcure Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
9,203.00
5,452.00
3,751.00
68.80%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
9,203.00
5,452.00
3,751.00
68.80%
Expenditure (Ex Depriciation)
Stock Adjustments
-432.00
37.00
-469.00
-1,267.57%
Raw Materials Consumed
4,090.00
1,146.00
2,944.00
256.89%
Power & Fuel Cost
135.00
73.00
62.00
84.93%
Employee Cost
1,552.00
1,291.00
261.00
20.22%
Operating Expenses
443.00
223.00
220.00
98.65%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
746.00
651.00
95.00
14.59%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
306.00
204.00
102.00
50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
7,457.00
4,058.00
3,399.00
83.76%
Operating Profit (PBDIT) excl Other Income
1,745.00
1,394.00
351.00
25.18%
Other Income
131.00
172.00
-41.00
-23.84%
Operating Profit (PBDIT)
1,877.00
1,566.00
311.00
19.86%
Interest
143.00
16.00
127.00
793.75%
Profit before Depriciation and Tax
1,733.00
1,550.00
183.00
11.81%
Depreciation
415.00
173.00
242.00
139.88%
Profit Before Taxation & Exceptional Items
1,318.00
1,377.00
-59.00
-4.28%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,287.00
1,377.00
-90.00
-6.54%
Provision for Tax
345.00
321.00
24.00
7.48%
Profit After Tax
941.00
1,056.00
-115.00
-10.89%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,312.00
3,671.00
-359.00
-9.78%
Profit Available for appropriations
4,237.00
4,727.00
-490.00
-10.37%
Appropriations
4,237.00
4,727.00
-490.00
-10.37%
Equity Dividend (%)
36%
1400%
-1,364.00
Earnings Per Share
48.77
84.53
-35.76
-42.30%
Profit And Loss - Net Sales
Net Sales 9,203.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.56% vs 18.59% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,745.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.85% vs 19.45% in Mar 2025
Profit And Loss - Interest
Interest 143.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -18.27% vs -25.88% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 941.27 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 33.05% vs 34.10% in Mar 2025






